Patent details

Basic Information

Publication number:

EP3676279

PCT Application Number:

US2018048666

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP187665435

PCT Publication Number:

WO2019046500

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS

French Title of Invention:

DINUCLÉOTIDES CYCLIQUES UTILISÉS EN TANT QU'AGENTS ANTICANCÉREUX

German Title of Invention:

CYCLISCHE DINUKLEOTIDE ALS ANTIKREBSMITTEL

SPC Number:

Dates

Filing date:

30/08/2018

Grant date:

01/12/2021

EP Publication Date:

08/07/2020

PCT Publication Date:

07/03/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/12/2021

EP B1 Publication Date:

01/12/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

30/08/2022

Expiration date:

30/08/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/11/2021

 

 

Name:

Bristol-Myers Squibb Company

Address:

Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Inventor

1

Name:

DODD, Dharmpal S.

Address:

United States (US)

2

Name:

ZHANG, Yong

Address:

United States (US)

3

Name:

FINK, Brian E.

Address:

United States (US)

Priority

Priority Number:

201762552680 P

Priority Date:

31/08/2017

Priority Country:

United States (US)

Classification

IPC classification:

C07H 21/02; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202148

Publication date:

01/12/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages